1 |
Van den Brule, F. A., C. Buicu, A. Berchuck, R. C. Bast, M. Deprez, F-T. Liu, D. N. W. Cooper, C. Pieters, M. E. Sobel and V. Castronovo. 1996. Expression of the 67-kDa laminin receptor, galectin-1 and galectin-3 in advanced human uterine adenocarcinoma. Hum. Pathol. 27, 1185-1191
DOI
ScienceOn
|
2 |
Westendorp, M. O., M. Li-Weber, R. W. Frank and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68, 4177-4185
|
3 |
Yang, R. Y., D. K. Hsu and F-T. Liu. 1996. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93, 6737-6742
|
4 |
Hsu, D. K., R. Y. Yang, Z. Pan, L. Yu, D. R. Salomon, W. P. Fung-Leung and F-T. Liu. 2000. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156, 1073-1083
DOI
ScienceOn
|
5 |
Konstantinov, K. N., B. A. Robbins and F-T. Liu. 1996. Galectin-3, a galactoside-binding animal lectin, is a marker of anaplastic larger-cell lymphoma. Am. J. Pathol. 148, 25-30
|
6 |
Liu, F-T., D. K. Hsu, R. I. Zuberi, I. Kuwahara, E. Y. Chi and W. R. Jr. Henderson. 1995. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147, 1016-1028
|
7 |
Matarrese, P., O. Fusco, N. Tinari, C. Natoli, F-T. Liu, M. L. Semeraro, W. Malorni and S. Iacobelli. 2000. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 85, 545-54
DOI
ScienceOn
|
8 |
Buonaguro, L., G. Barillari., H. K Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J. Virol. 66, 7159-7167
|
9 |
Ganju, R. K., N. Munshi, B. C. Nair, Z. Y. Liu, P. Gill and J. E. Groopman. 1998. Human immunodeficiency virus tat modulates the FIk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J. Virol. 72, 6131-6137
|
10 |
Xu, X. C., A. K. El-Naggar and R. Lotan. 1995. Differential expression of galectin-1 and galectin-3 in thyroid tumors: potential diagnostic implications. Am. J. Pathol. 147, 815-822
|
11 |
Nachtigal, M., M. L. Nagpal, P. Greenspan, S. A. Nachtigal and A. Legrand. 1989. Characterization of a continuous smooth muscle cell line derived from rabbit aorta. In Vitro Cell Dev. Biol. 5, 892-898
|
12 |
Menegon, A, C. Leoni, F. Benfenati and F. Valtorta. 1997. Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem. Biophys. Res. Commun. 238, 800-805
DOI
ScienceOn
|
13 |
Moutsatsos, I. K., M. Wade, M. Schindler and J. L. Wang. 1987. Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 84, 6452-6456
|
14 |
Nachtigal, M., Z. Al-Assaad, E. P. Mayer, K. Kim and M. Monsigny. 1998 Galectin-3 expression in human atherosclerotic lesions. Am. J. Pathol. 152, 1199-1208
|
15 |
Nangia-Makker, P., J. Ochieng, J. K. Christman and A. Raz. 1993. Regulation of the expression of galactosidebinding lectin during human monocytic differentiation. Cancer Res. 53, 5033-5037
|
16 |
Albini, A., R. Soldi, D. Giunciuglio, E. Giraudo, R. Benelli, L. Primo, D. Noonan, M. Salio, G. Camussi, W. Rockl and F. Bussolino. 1996. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat. Med. 2, 1371-1375
DOI
ScienceOn
|
17 |
Barondes, S. H., D. N. W. Cooper, M. A. Gitt and H. Leffler. 1994. Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269, 20807-20810
|
18 |
Castronovo, V., F. A. Van den Brule, P. Jackers, N. Clausse, F-T. Liu, C. Gillet and M. E. Sobel. 1996. Decreased expression of galectin-3 is associated with progression of human breast cancer. J. Pathol. 179, 43-48
DOI
ScienceOn
|
19 |
Dagher, S. F., J. L. Wang and R. J. Patterson. 1995. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 92, 1213-1217
|
20 |
Lotz, M. M., C. W. Jr. Andrews, C. A. Korzelius, E. C. Lee, D. G. Jr. Steele, A. Clarke and A. M. Mercurio. 1993. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. Natl. Acad. Sci. U.S.A. 90, 3466-3472
|
21 |
Hsu, D. K., C. A. Dowling, K. C. G. Jeng, J. T. Chen, R. Y. Yang and F-T. Liu. 1999. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int. J. Cancer 81, 519-526
DOI
ScienceOn
|
22 |
Fogel, S., M. Guittaut, A. Legrand, M. Monsigny and E. Hebert. 1999. The tat protein of HIV-I induces galectin-3 expression. Glycobiology 9, 383-387
DOI
ScienceOn
|
23 |
Frigeri, L. G., R. I. Zuberi and F-T. Liu. 1993. Epsilon BP, a beta-galactoside-binding animal lectin, recognizes IgE receptor (Fe epsilon RI) and activates mast cells. Biochemistry 32, 7644-7649
DOI
ScienceOn
|
24 |
Gaudin, J. C., C. Arar, M. Monsigny and A. Legrand. 1997. Modulation of the expression of the rabbit galectin-3 by p53 and Ha-ras proteins and PMA. Glycobiology 7, 1089-1098
DOI
ScienceOn
|
25 |
Hsu, D. K., S. R. Hammes, I. Kuwabar, W. C. Greene and F-T. Liu. 1996. Human T lymphotropic virus-1 infection of human T-Iymphocytes induces expression of the betagalactoside-binding lectin, galectin-3. Am. J. Pathol. 148, 1661-1670
|
26 |
Schroder, H. C., H. Ushijima, C. Theis, A. P. Seve, J. Hubert and W. E. Muller. 1995. Expression of nuclear lectin carbohydrate-binding protein 35 in human immunodeficiency virus type 1-infected Molt-3 cells. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9, 340-348
|
27 |
Agrwal, N., J. L. Wang and P. G. Voss. 1989. Carbohydratebinding protein 35. Levels of transcription and mRNA accumulation in quiescent and proliferating cells. J. Biol. Chem. 264, 17236-17242
|
28 |
Akahani, S., P. Nangia-Makker, H. Inohara, H. R. Kim and A. Raz. 1997. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57, 5272-5276
|
29 |
Raz, A., D. G. Zhu, V. Hogan, N. Shah, T. Raz, R. Karkash, G. Pazerini and P. Carmi. 1990. Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int. J. Cancer 46, 871-877
DOI
|
30 |
Sastry, K. J., H. R. Reddy, R. Pandita, K. Totpal and B. B. Aggarwal. 1990. HIV-1 tat gene induces tumor necrosis factor-beta (lymphotoxin) in a human B-lymphoblastoid cell line. J. Biol. Chem. 265, 20091-20093
|
31 |
Schwartz, O., J. L. Virelizier, L. Montagnier and U. Hazan. 1990. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene 88, 197-205
DOI
ScienceOn
|
32 |
Li, F-T. 1993. S-type mammalian lectins in allergic inflammation. Immunol. Today 14, 486-490
DOI
ScienceOn
|